[ad_1]
DUBLIN, Oct. 10, 2022 /PRNewswire/ — The “Vietnam Tuberculosis Therapeutics Market, By Disease Type (Active Tuberculosis v/s Latent Tuberculosis), By Therapy (First Line Therapy v/s Second Line Therapy), By Region, Competition Forecast & Opportunities, 2028” report has been added to ResearchAndMarkets.com’s offering.
The Vietnam tuberculosis therapeutics market is anticipated to register a robust growth in the forecast period, 2023-2027. Growing demands for effective treatment and efficient pharmaceuticals to control the growing instances of tuberculosis is driving the market growth.
Besides, increasing investments and grants for tuberculosis therapeutics are boosting the growth of the Vietnam tuberculosis therapeutics market. Earlier, tuberculosis has been a leading cause of death in Vietnam. The government is aggressively implementing programs and initiatives to control the tuberculosis rates such as the National Tuberculosis Control Programme (NTP).
Rising government measures and growing public awareness of communicable illnesses are also expected to fuel the Vietnam tuberculosis therapeutics market. Rising incidences of drug susceptible tuberculosis and increase in multi-drug resistant TB cases are some of the factors boosting the market growth. Besides. More R&D efforts towards drug development, emergence of effective drug alternatives in the market, and collaborations focused on the development of shorter treatment regimens to fight resistance and address unmet medical needs, which are expected to fuel the market growth.
The Vietnam The tuberculosis therapeutics market is segmented on the basis of disease type, therapy, competitive …
Full story available on Benzinga.com
[ad_2]
Source link
